Avanir Pharmaceuticals (United States)

Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect

Erik P. Pioro, Benjamin Rix Brooks, Jeffrey L. Cummings et al. · Annals of Neurology · 2010 · 368 citations

Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

Raymond T. Bartus, Tiffany Baumann, João Siffert et al. · Neurology · 2013 · 205 citations · Full text

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia

Jeffrey L. Cummings, Constantine G. Lyketsos, Elaine R. Peskind et al. · JAMA · 2015 · 197 citations

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

Hillel Panitch, Ronald A. Thisted, Richard Smith et al. · Annals of Neurology · 2006 · 175 citations

INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY

Raj K. Maturi, Ayala Pollack, Harvey S. Uy et al. · Retina · 2016 · 126 citations · Full text